Reverbtx
Founded 2023 · 20 employees on LinkedIn · 3 known investors
Find your way into Reverbtx
Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds. Its pipeline addresses cancer, autoimmune disease, and cell therapy support, with lead candidate AMP01 advancing toward clinical trials.
Investors · 3
Frequently asked questions
- What does Reverbtx do?
- Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds. Its pipeline addresses cancer, autoimmune disease, and cell therapy support, with lead candidate AMP01 advancing toward clinical trials.
- Who are Reverbtx's investors?
- Reverbtx's investors include InBC Investment Corp., Thin Air Labs, KdT Ventures.